-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 KPxyDpfvEZL1V7S7Rg8BJs8YVY0JeSJqP2idv1UczIIm4BkIfvurjASy9/U0CJn6
 okbJss9AHq+N2H22aU0l1Q==

<SEC-DOCUMENT>0001209191-03-021656.txt : 20030915
<SEC-HEADER>0001209191-03-021656.hdr.sgml : 20030915
<ACCEPTANCE-DATETIME>20030915183325
ACCESSION NUMBER:		0001209191-03-021656
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20030911
FILED AS OF DATE:		20030915

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LYLE CORINNE H
		CENTRAL INDEX KEY:			0001182467

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22890
		FILM NUMBER:		03896507

	MAIL ADDRESS:	
		STREET 1:		C/O EDWARDS LIFESCIENCES CORPORATION
		STREET 2:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGSTAT MEDICAL CORP
		CENTRAL INDEX KEY:			0000913610
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943076069
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		6300 DUMBARTON CIRCLE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94555
		BUSINESS PHONE:		5107894300

	MAIL ADDRESS:	
		STREET 1:		6300 DUMBARTON CIRCLE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94555
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?><ownershipDocument><schemaVersion>X0201</schemaVersion>    <documentType>4</documentType><periodOfReport>2003-09-11</periodOfReport><notSubjectToSection16>1</notSubjectToSection16><issuer><issuerCik>0000913610</issuerCik><issuerName>SANGSTAT MEDICAL CORP</issuerName>        <issuerTradingSymbol>SANG</issuerTradingSymbol></issuer><reportingOwner><reportingOwnerId><rptOwnerCik>0001182467</rptOwnerCik><rptOwnerName>LYLE CORINNE H</rptOwnerName></reportingOwnerId><reportingOwnerAddress><rptOwnerStreet1>6300 DUMBARTON CIRCLE</rptOwnerStreet1><rptOwnerStreet2></rptOwnerStreet2><rptOwnerCity>FREMONT</rptOwnerCity><rptOwnerState>CA</rptOwnerState><rptOwnerZipCode>94555</rptOwnerZipCode><rptOwnerStateDescription></rptOwnerStateDescription></reportingOwnerAddress><reportingOwnerRelationship><isDirector>1</isDirector><isOfficer>0</isOfficer><isTenPercentOwner>0</isTenPercentOwner><isOther>0</isOther></reportingOwnerRelationship></reportingOwner><nonDerivativeTable><nonDerivativeTransaction><securit
yTitle><value>Common Stock</value></securityTitle><transactionDate><value>2003-09-11</value></transactionDate><deemedExecutionDate></deemedExecutionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>D</transactionCode><equitySwapInvolved>0</equitySwapInvolved></transactionCoding><transactionTimeliness><value></value></transactionTimeliness><transactionAmounts><transactionShares><value>200</value></transactionShares><transactionPricePerShare><value>22.5</value><footnoteId id="F1" /></transactionPricePerShare><transactionAcquiredDisposedCode><value>D</value></transactionAcquiredDisposedCode></transactionAmounts><postTransactionAmounts><sharesOwnedFollowingTransaction><value>0</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership></ownershipNature></nonDerivativeTransaction><nonDerivativeTransaction><securityTitle><value>Common Stock</value></securityTitle><transactionDate><value
>2003-09-11</value></transactionDate><deemedExecutionDate></deemedExecutionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>M</transactionCode><equitySwapInvolved>0</equitySwapInvolved></transactionCoding><transactionTimeliness><value></value></transactionTimeliness><transactionAmounts><transactionShares><value>19000</value></transactionShares><transactionPricePerShare><value>18.49</value></transactionPricePerShare><transactionAcquiredDisposedCode><value>A</value></transactionAcquiredDisposedCode></transactionAmounts><postTransactionAmounts><sharesOwnedFollowingTransaction><value>19000</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership></ownershipNature></nonDerivativeTransaction><nonDerivativeTransaction><securityTitle><value>Common Stock</value></securityTitle><transactionDate><value>2003-09-11</value></transactionDate><deemedExecutionDate></deemedExecutionDate><transac
tionCoding><transactionFormType>4</transactionFormType><transactionCode>D</transactionCode><equitySwapInvolved>0</equitySwapInvolved></transactionCoding><transactionTimeliness><value></value></transactionTimeliness><transactionAmounts><transactionShares><value>19000</value></transactionShares><transactionPricePerShare><value>22.5</value><footnoteId id="F1" /></transactionPricePerShare><transactionAcquiredDisposedCode><value>D</value></transactionAcquiredDisposedCode></transactionAmounts><postTransactionAmounts><sharesOwnedFollowingTransaction><value>0</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership></ownershipNature></nonDerivativeTransaction></nonDerivativeTable><derivativeTable><derivativeTransaction><securityTitle><value>Option to Purchase Common Stock</value></securityTitle><conversionOrExercisePrice><value>18.49</value></conversionOrExercisePrice><transactionDate><value>2003-09-11</value></transacti
onDate><deemedExecutionDate></deemedExecutionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>M</transactionCode><equitySwapInvolved>0</equitySwapInvolved></transactionCoding><transactionTimeliness><value></value></transactionTimeliness><transactionAmounts><transactionShares><value>19000</value></transactionShares><transactionPricePerShare><value>22.5</value><footnoteId id="F1" /></transactionPricePerShare><transactionAcquiredDisposedCode><value>D</value></transactionAcquiredDisposedCode></transactionAmounts><exerciseDate><value>2003-09-11</value></exerciseDate><expirationDate><value>2012-07-10</value></expirationDate><underlyingSecurity><underlyingSecurityTitle><value>Common Stock</value></underlyingSecurityTitle><underlyingSecurityShares><value>19000</value></underlyingSecurityShares></underlyingSecurity><postTransactionAmounts><sharesOwnedFollowingTransaction><value>0</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwn
ership><value>D</value></directOrIndirectOwnership></ownershipNature></derivativeTransaction></derivativeTable><footnotes><footnote id="F1">Option vesting was accelerated and the underlying common stock and all other common stock owned by the reporting person was acquired by Genzyme Corporation ("Genzyme") pursuant to the Agreement and Plan of Merger by and among Genzyme, Swift Starboard Corporation and SangStat Medical Corporation.</footnote></footnotes><remarks>See attached footnote page.</remarks><ownerSignature><signatureName>Tamiko F. Lewis, Attorney-in-Fact for Corinne Lyle</signatureName><signatureDate>2003-09-15</signatureDate></ownerSignature></ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----